Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Jasper Therapeutics Inc | JSPRW | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.2075 | 03:45:53 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.2075 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.0351 - 0.3818 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 0.2075 | USD |
Jasper Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 376.9M | 15.06M | - | 0 | -64.47M | -4.28 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Jasper Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical JSPRW Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.215 | 0.217499 | 0.155 | 0.2097367 | 3,574 | -0.0075 | -3.49% |
| 1 Month | 0.1414 | 0.217499 | 0.1275 | 0.1975484 | 7,109 | 0.0661 | 46.75% |
| 3 Months | 0.22 | 0.2323 | 0.101 | 0.1718822 | 17,963 | -0.0125 | -5.68% |
| 6 Months | 0.0511 | 0.3818 | 0.0351 | 0.1567655 | 23,484 | 0.1564 | 306.07% |
| 1 Year | 0.1003 | 0.3818 | 0.0351 | 0.1282739 | 19,364 | 0.1072 | 106.88% |
| 3 Years | 1.73 | 2.24 | 0.016 | 0.521586 | 28,644 | -1.52 | -88.01% |
| 5 Years | 1.73 | 2.24 | 0.016 | 0.521586 | 28,644 | -1.52 | -88.01% |
Jasper Therapeutics Description
| Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy. |
